Go Pro
Thank you for registering! Take a moment to confirm your subscription to MarketBeat Daily Ratings so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:APDN

Applied DNA Sciences (APDN) Stock Price, News & Analysis

Applied DNA Sciences logo

About Applied DNA Sciences Stock (NASDAQ:APDN)

Key Stats

Today's Range
$4.61
$5.87
50-Day Range
$2.32
$6.15
52-Week Range
$0.29
$7.15
Volume
2.76 million shs
Average Volume
516,804 shs
Market Capitalization
$7.94 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

Applied DNA Sciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
1st Percentile Overall Score

APDN MarketRank™: 

Applied DNA Sciences scored higher than 1% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Applied DNA Sciences has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Applied DNA Sciences has received no research coverage in the past 90 days.

  • Read more about Applied DNA Sciences' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Applied DNA Sciences is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Applied DNA Sciences is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Applied DNA Sciences has a P/B Ratio of 0.03. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for APDN.
  • Dividend Yield

    Applied DNA Sciences does not currently pay a dividend.

  • Dividend Growth

    Applied DNA Sciences does not have a long track record of dividend growth.

  • Search Interest

    1 people have searched for APDN on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Applied DNA Sciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    0.17% of the stock of Applied DNA Sciences is held by insiders.

  • Percentage Held by Institutions

    22.22% of the stock of Applied DNA Sciences is held by institutions.

  • Read more about Applied DNA Sciences' insider trading history.

APDN Stock News Headlines

Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.tc pixel
Applied DNA Sciences Announces New CEO Appointment
Earnings Scheduled For August 26, 2025
Applied DNA Sciences Focuses on LineaRx for Growth
See More Headlines

APDN Stock Analysis - Frequently Asked Questions

Applied DNA Sciences Inc (NASDAQ:APDN) announced its quarterly earnings data on Thursday, August, 14th. The technology company reported ($34.00) earnings per share for the quarter, beating the consensus estimate of ($37.50) by $3.50. The technology company earned $0.30 million during the quarter, compared to analyst estimates of $1.28 million. Applied DNA Sciences had a negative trailing twelve-month return on equity of 136.17% and a negative net margin of 399.91%.

Applied DNA Sciences's stock reverse split before market open on Sunday, June 1st 2025.The 1-15 reverse split was announced on Sunday, June 1st 2025. The number of shares owned by shareholders was adjusted after the market closes on Sunday, June 1st 2025. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Applied DNA Sciences investors own include Zomedica (ZOM), Jumia Technologies (JMIA), Nano Dimension (NNDM), NIO (NIO), Virgin Galactic (SPCE), AST SpaceMobile (ASTS) and Advanced Micro Devices (AMD).

Company Calendar

Last Earnings
8/14/2025
Today
7/27/2026
Fiscal Year End
9/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
PROTECTION - SFTY
Sub-Industry
Business Services
Current Symbol
NASDAQ:APDN
CIK
744452
Employees
70
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($923.81)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$6.99 million
Net Margins
-399.91%
Pretax Margin
-394.30%
Return on Equity
-136.17%
Return on Assets
-101.95%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.76
Quick Ratio
2.60

Sales & Book Value

Annual Sales
$3.74 million
Price / Sales
2.12
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$215.25 per share
Price / Book
0.03

Miscellaneous

Outstanding Shares
1,291,000
Free Float
1,289,000
Market Cap
$7.94 million
Optionable
Optionable
Beta
0.15

Social Links


This page (NASDAQ:APDN) was last updated on 7/27/2026 by MarketBeat.com Staff.
From Our Partners